Cargando…
Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health
Gene therapy manipulates or modifies a gene that provides a new cellular function to treat or correct a pathological condition, such as cancer. The approach of using gene manipulation to modify patient’s cells to improve cancer therapy and potentially find a cure is gaining popularity. Currently, th...
Autores principales: | Thoidingjam, Shivani, Sriramulu, Sushmitha, Freytag, Svend, Brown, Stephen L., Kim, Jae Ho, Chetty, Indrin J., Siddiqui, Farzan, Movsas, Benjamin, Nyati, Shyam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088621/ https://www.ncbi.nlm.nih.gov/pubmed/37065938 http://dx.doi.org/10.1186/s41231-023-00144-w |
Ejemplares similares
-
A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma
por: Nyati, Shyam, et al.
Publicado: (2023) -
Collected Papers by the Staff of the Henry Ford Hospital
Publicado: (1926) -
Preclinical toxicology of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for prostate cancer
por: Freytag, Svend O, et al.
Publicado: (2015) -
Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer
por: Barton, Kenneth N., et al.
Publicado: (2020) -
Ford Madox Ford/
por: Judd, Alan 1946-